Vascular Disease and Surgery

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

Balloon-expandable versus Self-expanding Valves

Published:

10 November 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023:2;e41.

Management of Coronary Artery Disease from Late Kawasaki Disease

Published:

04 September 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e34.

Corrigendum to: Reasons for Coronary Artery Bypass Graft Rejection: Patients’ and Surgeons’ Perspectives

Published:

24 August 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e31.

Evaluation of Subclinical LV Systolic Dysfunction by GLS Using 2D-STE

Published:

08 August 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e30.